Trends and Outcomes of Mechanical Circulatory Support in Acute Myocardial Infarction and Cardiogenic Shock Patients Undergoing Coronary Artery Bypass Grafting
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
BACKGROUND: We sought to describe trends and outcomes of mechanical circulatory support (MCS) use in acute myocardial infarction and cardiogenic shock (AMI-CS) patients undergoing coronary artery bypass grafting (CABG). METHODS: We identified all patients with AMI-CS undergoing CABG in the Society of Thoracic Surgeons Adult Cardiac Surgery Database from 2011 to 2022. Pre-, intra-, and post-operative use of intra-aortic balloon pump (IABP), catheter-based temporary MCS (tMCS), and extracorporeal membrane oxygenation (ECMO) were examined using multivariable regression and trends analyses. The primary outcome was operative mortality. RESULTS: In total, 34,015 patients with AMI-CS underwent CABG during the study period. The annualized volume ranged from 2,964 in 2011 to 2,646 in 2022, while operative mortality decreased from 24.2% in 2011 to 19.0% in 2022 (p for trend <0.001). Pre-operatively, IABP was used in 23,833 (70.1%) patients, tMCS in 2,173 (6.4%) patients, ECMO in 173 (0.5%) patients, and multiple devices in 499 (1.5%). Pre-operative IABP use decreased from 2,210 (74.6%) in 2011 to 1,710 (64.6%) in 2022, while pre-operative tMCS use increased from 38 (1.3%) in 2011 to 298 (11.3%) in 2022. Pre-operative ECMO (p for trend =0.004) or multiple device use (p for trend <0.001) remained rare but increased over time. Pre-operative IABP use was associated with lower operative mortality (18.0% vs 24.4%, aOR 0.76 [95% CI, 0.71-0.82], p<0.001). CONCLUSIONS: Operative mortality in AMI-CS patients undergoing CABG has decreased, while operative volumes have remained stable. IABP remains the most frequently used MCS, although its usage is declining in favor of tMCS.